Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,523.90
+16.45 (0.36%)
At close: Jun 2, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 204.29 billion as of June 3, 2026. Its market cap has increased by 3.27% in one year.
Market Cap
204.29B
Enterprise Value
173.88B
Revenue
25.20B
Ranking
n/a
PE Ratio
28.28
Stock Price
4,523.90
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 204.29B, an increase of 518.76%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 206.53B | -9.49% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 558.66B |
| GlaxoSmithKline Pharmaceuticals | 370.71B |
| J. B. Chemicals & Pharmaceuticals | 341.60B |
| AstraZeneca Pharma India | 217.98B |
| Rubicon Research | 214.60B |
| Granules India | 192.50B |
| Jubilant Pharmova | 154.52B |
| Caplin Point Laboratories | 151.01B |